Kasner SE, Bath PM, Hill MD, Volpi JJ, et al. Recombinant Human Tissue Kallikrein-1 for Treating Acute Ischemic Stroke and Preventing Recurrence. Stroke 2025 Jan 6. doi: 10.1161/STROKEAHA.124.048858.
PMID: 39758014